Compugen Ltd (CGEN)
2.34
+0.48
(+25.81%)
USD |
NASDAQ |
May 22, 16:00
2.36
+0.02
(+0.85%)
After-Hours: 20:00
Compugen Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2022 | -20.68M |
| June 30, 2021 | -13.63M |
| June 30, 2020 | -11.57M |
| June 30, 2019 | -16.41M |
| June 30, 2018 | -7.849M |
| June 30, 2017 | -15.06M |
| June 30, 2016 | -7.731M |
| June 30, 2015 | -13.00M |
| Date | Value |
|---|---|
| June 30, 2014 | -6.711M |
| June 30, 2013 | -6.314M |
| June 30, 2012 | -5.543M |
| June 30, 2011 | -3.877M |
| September 30, 2010 | -3.448M |
| June 30, 2010 | -3.032M |
| September 30, 2009 | -5.373M |
| June 30, 2009 | -4.42M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-20.68M
Minimum
Jun 2022
-11.57M
Maximum
Jun 2020
-15.57M
Average
-15.02M
Median
Cash from Operations (Quarterly) Benchmarks
| Pluri Inc | -4.202M |
| BioLine Rx Ltd | 4.991M |
| XTL Biopharmaceuticals Ltd | -- |
| Can Fite Biofarma Ltd | -- |
| BiomX Inc | -11.36M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow Yield | -30.43% |